Cite
HARVARD Citation
Daramola, A. et al. (2023). A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG+ hybridomas in comparison to its recombinant allergen-drug conjugate. Immunotherapy advances. 3 (1), p. . [Online].